The CDC estimates that the 2024-2025 flu season has already resulted in at least 24 million illnesses, 310,000 ...
Bavarian Nordic (OTCPK:BVNRY) has received FDA approval for its vaccine Vimkunya for the prevention of chikungunya. The virus-like particle, or VLP, vaccine is approved for people aged 12 and older.
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers.On track for commercial launch in the U.S. in the ...
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention ...
Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.
Viral diseases remain a significant global health challenge, causing widespread morbidity and mortality. Advances in ...
The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...